Ausgabe 2/2005
Inhalt (11 Artikel)
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines
Jürgen Sonnemann, Jennifer Gänge, K. Saravana Kumar, Cornelia Müller, Peter Bader, James F. Beck
Resveratrol regulates cellular PKC α and δ to inhibit growth and induce apoptosis in gastric cancer cells
Mary Jo Atten, Ernesto Godoy-Romero, Bashar M. Attar, Thomas Milson, Matthew Zopel, Oksana Holian
Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel™
Ephraim Philip Lansky, Gregory Harrison, Paul Froom, Wen G. Jiang
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer
John Murren, Manuel Modiano, Shivaani Kummar, Caroline Clairmont, Merrill Egorin, Edward Chu, Mario Sznol
Transient respiratory failure possibly associated to imatinib
C. Lengerke, T. Brümmendorf, U. Herrlinger, M. Horger, L. Kanz, J. T. Hartmann
Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study
Peter Schmid, Marcus Schweigert, Thomas Beinert, Bernd Flath, Orhan Sezer, Kurt Possinger
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group
G. Goss, H. Hirte, W. H. Miller Jr, I. A. J. Lorimer, D. Stewart, G. Batist, D. A. E. Parolin, P. Hanna, S. Stafford, J. Friedmann, W. Walsh, S. Mathews, L. Douglas, L. K. Seymour
Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer
Maik Kilian, Jan Ilga Gregor, Ina Heukamp, Chris Braumann, Hans Guski, Ingolf Schimke, Martin Karl Walz, Christoph Andreas Jacobi, Frank Axel Wenger
A phase II trial of ZD1839 (Iressa™) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer
Mary J. MacKenzie, Holger W. Hirte, Goss Glenwood, Maroun Jean, Rakesh Goel, Pierre P. Major, Wilson H. Miller Jr., Lawrence Panasci, Ian A. J. Lorimer, Gerald Batist, Sarah Matthews, Lynn Douglas, Lesley Seymour
Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial
Chao Ta-Chung, Chu Zyting, Tseng Ling-Ming, Chiou Tzeon-Jye, Hsieh Ruey-Kuen, Wang Wei-Shu, Yen Chueh-Chuan, Yang Muh-Hwa, Hsiao Liang-Tsai, Liu Jin-Hwang, Chen Po-Min
Phase II trial of fenretinide in advanced renal carcinoma
Ulka Vaishampayan, Lance K. Heilbrun, Ralph E. Parchment, Vikash Jain, James Zwiebel, Ramesh R. Boinpally, Patricia LoRusso, Maha Hussain